Comparison

PDHK-IN-4 European Partner

Item no. HY-146552-1ea
Manufacturer MedChem Express
Amount 1 ea
Quantity options 100 mg 1 ea
Category
Type Chemicals
Specific against other
Citations [1]Bessho Y, et al. Structure-based drug design of novel and highly potent pyruvate dehydrogenase kinase inhibitors. Bioorg Med Chem. 2021 Dec 15;52:116514
Smiles O=C(C1=CC=C([C@@H]2CN(C3=C4C(NC5=C4C=CC=C5C6CC6)=NC(C)=N3)[C@H](CO)C2)N1)O
ECLASS 10.1 32160000
ECLASS 11.0 32160000
UNSPSC 12000000
Shipping Condition Room temperature
Available
Manufacturer - Type
Reference compound
Manufacturer - Applications
Metabolism-sugar/lipid metabolism
Manufacturer - Targets
PDHK
Shipping Temperature
Room temperature
Molecular Weight
431.49
Product Description
PDHK-IN-4 (Compound 30) is a potent inhibitor of PDHK with IC50s of 0.0051 and 0.0122 μM for PDHK2 and PDHK4, repectively. Pyruvate dehydrogenase kinases (PDHKs) are fascinating agent targets for numerous diseases, including diabetes and cancers. PDHK-IN-4 has the potential for the research of cancer diseases[1].
Manufacturer - Research Area
Cancer; Metabolic Disease
Solubility
10 mM in DMSO
Manufacturer - Pathway
Metabolic Enzyme/Protease
Clinical information
No Development Reported

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 1 ea
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close